Trump vaccine czar makes $3.4M windfall as firm reports progress on coronavirus shot and stock soars
NEW YORK DAILY NEWS |
MAY 18, 2020 | 9:20 AM
A controversial biotech firm is claiming early positive progress on its trial of a coranavirus vaccine — giving a massive financial boost to President Trump’s newly minted vaccine czar.
The report sent Moderna stock soaring by up to 34% in pre-market trading Monday. It was trading up a more modest 22% by midmorning.
he stock spike temporarily added at least $3.4 million to the bottom line of Moncef Slaoui, the just-named vaccine czar who was on the board of Moderna until his appointment.
Slaoui, a veteran Big Pharma exec, holds 156,000 stock options that increased in value by more than $3 million on the Monday morning news.
More
https://www.nydailynews.com/coronavirus/ny-coronavirus-moderna-vaccine-trump-slaoui-moncef-elizabeth-warren-20200518-aua4tkcy4vexlcl4fgppqhyfeu-story.html
= new reply since forum marked as read
